An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo

Journal of Clinical Investigation

Volumn 101, Issue 1, 1998, Pages 223-234

  Nikoulin, Igor R ^a   Curtiss, Linda K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Apolipoprotein E; Cholesterol; Peptides; Proteoglycans; Receptors

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

EID: 0031975646     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1099     Document Type: Article

References (41)

1. Mahley, R.W. 1998. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:622-630.
2. Mahley, R.W., K.H. Weisgraber, M.M. Hussain, B. Greenman, M. Fisher, T. Vogel, and M. Gorecki. 1989. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83: 2125-2130.
3. Yamada, N., H. Shimano, H. Mokuno, S. Ishibashi, T. Gotohda, M. Kawakami, Y. Watanabe, Y. Akanuma, T. Murase, and F. Takaku. 1989. Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA. 86:665-669.
4. Shimano, H., N. Yamada, M. Katsuki, K. Yamamoto, T. Gotoda, K. Harada, M. Shimada, and Y. Yazaki. 1992. Plasma lipoprotein metabolism in transgenic mice overexpossing apolipoprotein E. Eur. J. Clin. Invest. 90:2084-2091.
5. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
6. Piedrahita, J.A., S.H., Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
7. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
8. Boisvert, W.A., J. Spangenberg, and L.K. Curtiss. 1995. Treatment of severe hypercholesterolemia apolipopotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96:1118-1124.
9. Dyer, C.A., and L.K. Curtiss. 1991. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J. Biol. Chem. 266:22803-22806.
10. Dyer, C.A., D.P. Cistola, G.C. Parry, and L.K. Curtiss. 1995. Structural features of synthetic peptides apolipoprotein E that bind the LDL receptor. J. Lipid Res. 36:80-88.
11. Dyer, C.A., R.S. Smith, and L.K. Curtiss. 1991. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J. Biol. Chem. 266:15009-15015.
12. Herz, J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K.K. Stanley. 1988. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7:4119-4127.
13. Kowal, R.C., J. Herz, J.L. Goldstein, V. Esser, and M.S. Brown. 1989. Low density lipoprotein receptor related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86: 5810-5814.
14. Mahley, R.W., Z.-S. Ji, W.J. Brecht, R.D. Miranda, and D. He. 1994. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann. NY Acad. Sci. 737:39-52.
15. Richardson, P.D., M.J. Davies, and G.V.R. Born. 1989. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2(8669):941-944.
16. Jorgensen, W.L., J. Chandrasekhas, R.W. Imprey, M.L. Klein. 1983. Comparison of simple potential functions for simulation liquid water. J. Chem. Phys. 79:926-935.
17. Curtiss, L.K., and R.S. Smith. 1988. Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides. J. Biol. Chem. 263:13779-13785.
18. Markwell, M.A.K., S.M. Haas, L.L. Bieber, and N.E.A. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
19. Brand, K., C.L. Banka, N. Mackman, R.A. Terkeltaub, S.-T. Fan, and L.K. Curtiss. 1994. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arteriorscler. Thromb. 14: 790-797.
20. Goldstein, J.L., and M.S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J. Biol. Chem. 249:5153-5162.
21. Gamble, W., M. Voughan, H.S. Kruth, and J. Avigan. 1978. Procedure for determination of free and total cholesterol in micro-or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19:1068-1070.
22. Farndale, R. W., C.A. Sayers, and A.J. Barret. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9:247-248.
23. Farndale, R.W., D.J. Buttle, and A.J. Barret. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem. Biophys. Acta. 883:173-177.
24. Sparrow, J.T., D.A. Sparrow, A.R. Culwell, and A.M. Gotto. 1985. Apolipoprotein E: Phospholipid binding studies with synthetic peptides containing the putative receptor binding region. Biochemistry. 24:6984-6988.
25. Ponsin, G., J.T. Sparrow, A.M. Gotto, Jr., and H.J. Pownall. 1986. In vivo interaction of synthetic acetylated apoE peptides with high density lipoprotein in rat. J. Clin. Invest. 77:559-567.
26. Ponsin, G., K. Strong, A.M. Gotto, Jr., J.T. Sparrow, and H.J. Pownall. 1984. In vitro binding of synthetic acetylated lipid-associating peptides to high-density lipoproteins: Effect of hydrophobicity. Biochemistry. 23:5337-5342.
27. Westerlund, J.A., and K.H. Weisgraber. 1993. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268:15745-15750.
28. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science. 234:179-186.
29. Herz, J., J.L. Goldstein, D.K. Strickland, Y.K. Ho, and M.S. Brown. 1991. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 266: 21232-21238.
30. Medh, J.D., G.L. Fry, S.L. Bowen, M.W. Pladet, D.K. Strickland, and D.A. Chappel. 1995. The 39-kDa receptor associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270:536-540.
31. Ji, Z.-S., W.J. Brecht, R.D. Miranda, M.M. Hussain, T.L. Innerarity, and R.W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160-10167.
32. Ji, Z.-S., S. Fazio, Y.-L. Lee, and R.W. Mahley. 1994. Secretion-culture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269:2764-2772.
33. Mims., M.P., A.T. Darnule, R.W. Tovar, H.J. Pownall, D.A. Sparrow, J.T. Sparrow, D.P. Via, and L.C. Smith. 1994. A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor. J. Biol. Chem. 269:20539-20547.
34. Pitas, R.F., T.L. Innerarity, K.S. Arnold, and R.W. Mahley. 1979. Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc. Proc. Natl. Acad. Sci. USA. 76:2311-2315.
35. Innerarity, T.L., R.E. Pitas, and R.W. Mahley. 1979. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254:4186-4190.
36. Pitas, R.F., T.L. Innerarity, and R.W. Mahley. 1980. Cell surface receptor binding of phospholipid -protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J. Biol. Chem. 255:5454-5460.
37. Weisgraber, K.H., S.C. Rall, Jr., R.W. Mahley, Y.L. Marcel, and J.T. Sparrow. 1986. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E. J. Biol. Chem. 261:2068-2076.
38. Cardin, A.D., N. Hirose, D.T. Blankenship, R.L. Jackson, J.A. Harmony, D.A. Sparrow, and J.T. Sparrow. 1986. Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem. Biophys. Res. Commun. 134:783-789.
39. Ishibashi, S., J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown. 1994. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E. or both proteins. Proc. Natl. Acad. Sci. USA. 91:4431-4435.
40. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89:9252-9256.
41. Langer, R. 1990. New methods of drug delivery. Science. 249:1527-1533.